Literature DB >> 11794202

Therapy for acute hepatitis C.

J H Hoofnagle.   

Abstract

Mesh：

Substances：

Year:  2001        PMID： 11794202     DOI： 10.1056/NEJM200111153452013

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  6 in total

1.  Clinical Trials Report.

Authors:  David A. Bobak
Journal:  Curr Infect Dis Rep       Date:  2002-04       Impact factor: 3.725

2.  Hepatitis C, illicit drug use and public health: does Canada really have a viable plan?

Authors:  Benedikt Fischer; Kate Kalousek; Jürgen Rehm; Jeff Powis; Mel Krajden; Jens Reimer
Journal:  Can J Public Health       Date:  2006 Nov-Dec

3.  Risk factors for hepatitis C virus acquisition and predictors of persistence among Egyptian children.

Authors:  Gamal Esmat; Mohamed Hashem; Mona El-Raziky; Wafaa El-Akel; Suzan El-Naghy; Nehal El-Koofy; Rokaya El-Sayed; Rasha Ahmed; Mohamed Atta-Allah; Mohamed Abdel Hamid; Samer S El-Kamary; Hanaa El-Karaksy
Journal:  Liver Int       Date:  2011-09-15       Impact factor: 5.828

4.  Prevalence of HBV and HCV among blood donors in Kosovo.

Authors:  Hajrullah Fejza; Skender Telaku
Journal:  Virol J       Date:  2009-02-13       Impact factor: 4.099

Review 5.  Managing occupational risks for hepatitis C transmission in the health care setting.

Authors:  David K Henderson
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

6.  Treatment of acute hepatitis C virus infection with interferon-alpha 2b and ribavirin: case report and review of the literature.

Authors:  Hakan Leblebicioglu; Derya Bayirli; Saban Esen; Mustafa Sunbul; Cafer Eroglu
Journal:  Ann Clin Microbiol Antimicrob       Date:  2002-10-14       Impact factor: 3.944
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.